Skip to main content

Royalty Pharma

  • | Investor (buy-side or sell-side research)
Royalty Pharma
Royalty Pharma acquires royalties on Phase 2+ biopharmaceutical products. 8 of the 25 world's top-selling medicines are represented in our portfolio of more than 40 royalty streams. We have done the 9 largest royalty deals.

Address

New York
NY
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors